Skip to main content
. 2021 Sep 17;61(5):2016–2024. doi: 10.1093/rheumatology/keab716

Fig. 1.


Fig. 1

Survival outcomes

(A) Kaplan–Meier survival curves comparing IBM patients (blue line), inflammatory myopathy patients (red line) and population controls (orange line). (B) Clear separation in survival curves for IBM patients treated with corticosteroids (blue line) compared with untreated IBM patients (red line). IBM: inclusion body myositis.